Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens.
about
Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics.Investigational HIV integrase inhibitors in phase I and phase II clinical trials.Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update.
P2860
Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Switching regimens in virologi ...... r (INSTI)-containing regimens.
@en
type
label
Switching regimens in virologi ...... r (INSTI)-containing regimens.
@en
prefLabel
Switching regimens in virologi ...... r (INSTI)-containing regimens.
@en
P2093
P2860
P356
P1433
P1476
Switching regimens in virologi ...... r (INSTI)-containing regimens.
@en
P2093
P2860
P356
10.1111/HIV.12440
P478
17 Suppl 5
P577
2016-10-01T00:00:00Z